Thyroxine in goiter, H. pylori infection, and gastritis.
Dietrich
Johannes W
JW
Boehm
Bernhard O
BO
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000327:Adsorption / Q000187:drug effects; D000897:Anti-Ulcer Agents / Q000494:pharmacology* / Q000627:therapeutic use; D001562:Benzimidazoles / Q000494:pharmacology* / Q000627:therapeutic use; D001682:Biological Availability; D005744:Gastric Acid / Q000378:metabolism*; D005756:Gastritis / Q000378:metabolism; D006042:Goiter / Q000188:drug therapy / Q000378:metabolism; D016481:Helicobacter Infections; D006801:Humans; D006863:Hydrogen-Ion Concentration; D009853:Omeprazole / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D000077402:Pantoprazole; D054328:Proton Pump Inhibitors; D013454:Sulfoxides / Q000494:pharmacology* / Q000627:therapeutic use; D013974:Thyroxine / Q000493:pharmacokinetics*
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000897:Anti-Ulcer Agents; D001562:Benzimidazoles; D054328:Proton Pump Inhibitors; D013454:Sulfoxides; D000077402:Pantoprazole; D009853:Omeprazole; D013974:Thyroxine